Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

25.77
-1.2200-4.52%
Post-market: 25.00-0.7700-2.99%19:36 EDT
Volume:831.91K
Turnover:21.15M
Market Cap:1.52B
PE:-20.08
High:26.25
Open:26.22
Low:24.30
Close:26.99
Loading ...

Buy Rating Affirmed for Janux Therapeutics Inc. Amid Promising Clinical Data and Strategic Advancements

TIPRANKS
·
03 Dec 2024

Janux Therapeutics Shares Soar 66% Premarket After Co Reports Strong Early-Stage Data for Prostate Cancer Drug

THOMSON REUTERS
·
03 Dec 2024

Janux Therapeutics price target raised to $70 from $63 at H.C. Wainwright

TIPRANKS
·
03 Dec 2024

Janux Therapeutics Shares Soar Over 70% in Overnight Trading Following Prostate Cancer Treatment Results

Dow Jones
·
03 Dec 2024

Janux Therapeutics Inc : Btig Raises Target Price to $100 From $82

THOMSON REUTERS
·
03 Dec 2024

Stocks to Watch: Zscaler, Janux Therapeutics, TransMedics

Dow Jones
·
03 Dec 2024

BRIEF-Janux Announces Doses Selected For Phase 1B Expansion Trials

Reuters
·
03 Dec 2024

Janux Announces Doses Selected for Phase 1B Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for Janx007 in Mcrpc

THOMSON REUTERS
·
03 Dec 2024

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

Business Wire
·
03 Dec 2024

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Business Wire
·
25 Nov 2024

Janux Therapeutics initiated with an Outperform at Leerink

TipRanks
·
23 Nov 2024

Leerink Initiates Janux Therapeutics at Outperform With $79 Price Target

MT Newswires Live
·
22 Nov 2024

Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
16 Nov 2024

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), 89bio (ETNB) and Ardent Health Partners, Inc. (ARDT)

TIPRANKS
·
11 Nov 2024

Janux Therapeutics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
08 Nov 2024

Janux Therapeutics Inc (JANX) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
07 Nov 2024

Janux Therapeutics price target raised to $82 from $62 at BTIG

TIPRANKS
·
07 Nov 2024

Buy Rating for Janux Therapeutics Driven by Promising Pipeline and Strong Financial Position

TIPRANKS
·
07 Nov 2024

Janux Therapeutics Inc (JANX) Receives a Buy from BTIG

TIPRANKS
·
07 Nov 2024

Promising Phase I Trial Results and Tolerability Boost Buy Rating for Janux Therapeutics’ JANX007 in mCRPC Treatment

TIPRANKS
·
07 Nov 2024